Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Pharmaceutical Robots Market to Exceed a Value of US$ 250.46 Mn by 2026, Says TMR

The global pharmaceutical robots market was valued at US$ 92.73 Mn in 2017 and is projected to expand at a cumulative annual growth rate (CAGR) of more than 12.1% from 2018 to 2026, according to a new report titled ‘Pharmaceutical Robots Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 – 2026’ published by Transparency Market Research (TMR) in May 2018. The report states that high adoption of robots, robust pharmaceutical industry across the globe, increase in funding for robotics research, and launch of newer therapies etc. are expected to spur the expansion of the pharmaceutical robots market during the forecast period from 2018 to 2026. Asia Pacific and Europe are projected to dominate the global pharmaceutical robots market in the near future, primarily due to rise in the number of domestic robot companies, blooming pharmaceutical sector, and rise in the number of conferences and exhibitions, and increase in funding in the industrial robots industry in these regions.

Asia Pacific is estimated to dominate the global pharmaceutical robots market by the end of 2026. This is due to the presence of a large number of local pharmaceutical companies, robot strategy adopted by countries such as China and Japan, and various initiatives undertaken by governments and non-profit organizations to promote awareness regarding the benefits offered by robotics. The pharmaceutical robots market in Asia Pacific is expected to expand at a CAGR of more than 13% from 2018 to 2026.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=44444

Technological Advancements and Significant Penetration of Robotics to Fuel the Global Market

Pharmaceutical robots are adept at performing tasks at rates that far exceed human capability. These robots are capable of functioning in perilous settings in proximity to biological dangers such as threat of radioactive contamination and toxic chemotherapy compounds. Robots are used in applications such as drug discovery, pharmaceutical and medical device manufacturing, and performing blood sample testing. Moreover, pharmaceutical companies are utilizing robots on large scale for scientific research. Factors such as rise in awareness about robotic machines and their increasing usage are leading to generation of large revenue for pharmaceutical robots market segment. The ability of these robots to inspect as well as pack drugs in pharmaceutical companies and laboratories is fuelling the market. The newest updated robots are included in the collaborative robots segment, which is expected expand at a high CAGR over the forecast period. These robots offer new and advanced technology and permit interaction between humans and robots. Also, these robots are economical and offer easy maintenance.

Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=44444

Collaborative Robots to be an Attractive Product Segment

The report offers detailed segmentation of the global pharmaceutical robots market based on type, application, and end-user. In terms of type, the collaborative robots segment is anticipated to expand at a significant CAGR during the forecast period. Collaborative robots are widely used in the life sciences sector owing to the accuracy, efficiency, and reproducibility offered by them. Moreover, collaborative robots can work alongside humans. Collaborative robots are economical, lightweight, and require minimum skills to be operated upon. These factors are expected to propel the collaborative robots segment in the coming years.

Picking and Packaging Segment Dominates the Market

In terms of application, the picking and packaging segment is projected to dominate the global pharmaceutical robots market during the forecast period and is estimated to expand at a CAGR of more than 12% from 2018 to 2026. There has been a tremendous rise in demand for personalized packaging leading to the increased usage of robots. The advantages offered by robotic machines in the field of pharmaceuticals include speed, accurate track and trace, and optimal floor space utilization. A large number of traditional robots such as VS-068A2 and VP-6242G produced by Denso Wave Incorporated are used for picking and packaging. Thus, picking and packaging is regarded as the most apt usage of robots.

Request a Sample of Pharmaceutical Robots Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=44444

Pharmaceutical Companies are Prominent End-users in the Market

In terms of end-user, the pharmaceutical companies segment is projected to hold a dominant share of the global pharmaceutical robots market during the forecast period. The segment is likely to expand at CAGR of 12.8% from 2018 to 2026. Factors such as rise in adoption of robots in the pharmaceutical sector owing to rise in drug discoveries and development are fuelling the expansion of the segment. Moreover, there has been an increase in development of personalized medicine and clinical trials in the pharmaceutical sector, which is further propelling the market.

Significant Incremental Opportunity in Asia Pacific Region

In terms of value, Asia Pacific dominated the global pharmaceutical robots market in 2017. The market share of the region is estimated to rise by the end of 2026. The dominance of the Asia Pacific region can be primarily attributed to the presence of a large number of local pharmaceutical companies in countries such as Japan and China. The local presence of leading pharmaceutical companies with large manufacturing units in these countries is expected to propel expansion of this region. The pharmaceutical robots market in Asia Pacific is anticipated to expand at a rapid rate during the forecast period.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=44444

Key Trend of Mergers and Acquisitions and New Product Development in the International Market is Observed among Leading Players

The report also provides profiles of the leading players operating in the global pharmaceutical robots market. Kawasaki Heavy Industries, Ltd., FANUC America Corporation, ABB Ltd., Yaskawa Electric Corporation, Denso Wave Inc., and Universal Robots A/S are some of the prominent players in the market with proprietary products and technologies. The major growth strategies adopted by these companies include mergers & acquisitions, new product development, as well as regional expansions. For instance, in 2016, FANUC America Corporation opened four new facilities, relocated three facilities, and added three new regional training centers. In 2017, Universal Robots launched Universal Robots Academy that offers free online training in robot programming in order to raise awareness about automation.

Popular Research Reports by TMR:

Robotic Rehabilitation and Assistive Technologies Market:
Healthcare Robots Market:

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.